aluates Reports

$ 0.0

Automative

Global CAR-T Therapy for Hematological Cancer Market Research Report 2024

Published Date: January 2025

Report Code: QYRE-Auto-0P19193

BUY CHAPTERS

Global CAR-T Therapy for Hematological Cancer Market Research Report 2024

Code: QYRE-Auto-0P19193

Report

January 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Gilead Sciences

Bristol–Myers Squibb

J & J

JW Therapeutics

FOSUNKite

CAR-T Therapy for Hematological Cancer Market Size

The global market for CAR-T Therapy for Hematological Cancer was valued at US$ 4087 million in the year 2023 and is projected to reach a revised size of US$ 21680 million by 2030, growing at a CAGR of 26.0% during the forecast period.

CAR-T Therapy for Hematological Cancer Market

CAR-T (Chimeric Antigen Receptor T-cell) therapy is a cutting-edge immunotherapy for hematological cancers, involving the genetic modification of a patient’s T cells to express synthetic receptors targeting specific antigens on cancer cells. These engineered T cells are expanded in the lab and reintroduced into the patient, where they can recognize and destroy cancerous cells with high specificity. Key features include its remarkable efficacy in treating certain blood cancers like B-cell lymphomas, leukemias, and multiple myeloma, particularly in patients with relapsed or refractory disease, and its potential for long-term remission. CAR-T therapy is primarily applied in advanced hematological malignancies and is being explored for broader indications through ongoing clinical trials. Despite its promise, challenges such as high cost, manufacturing complexity, and management of severe side effects like cytokine release syndrome (CRS) remain areas of active research.

North American market for CAR-T Therapy for Hematological Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for CAR-T Therapy for Hematological Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for CAR-T Therapy for Hematological Cancer in Lymphoma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of CAR-T Therapy for Hematological Cancer include Novartis, Gilead Sciences, Bristol-Myers Squibb, J&J, JW Therapeutics, FOSUNKite, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for CAR-T Therapy for Hematological Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Therapy for Hematological Cancer.

The CAR-T Therapy for Hematological Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CAR-T Therapy for Hematological Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CAR-T Therapy for Hematological Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CAR-T Therapy for Hematological Cancer Market Report

Report Metric	Details
Report Name	CAR-T Therapy for Hematological Cancer Market
Accounted market size in year	US$ 4087 million
Forecasted market size in 2030	US$ 21680 million
CAGR	26.0%
Base Year	year
Forecasted years	2025 - 2030
Segment by Type	Target: CD19 Target: BCMA Others
Segment by Application	Lymphoma Multiple Myeloma Leukemia
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Gilead Sciences, Bristol-Myers Squibb, J&J, JW Therapeutics, FOSUNKite
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Therapy for Hematological Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is CAR-T Therapy for Hematological Cancer Market growing?

Ans: The CAR-T Therapy for Hematological Cancer Market witnessing a CAGR of 26.0% during the forecast period 2025-2030.

What is the CAR-T Therapy for Hematological Cancer Market size in 2030?

Ans: The CAR-T Therapy for Hematological Cancer Market size in 2030 will be US$ 21680 million.

Who are the main players in the CAR-T Therapy for Hematological Cancer Market report?

Ans: The main players in the CAR-T Therapy for Hematological Cancer Market are Novartis, Gilead Sciences, Bristol-Myers Squibb, J&J, JW Therapeutics, FOSUNKite

What are the Application segmentation covered in the CAR-T Therapy for Hematological Cancer Market report?

Ans: The Applications covered in the CAR-T Therapy for Hematological Cancer Market report are Lymphoma, Multiple Myeloma, Leukemia

What are the Type segmentation covered in the CAR-T Therapy for Hematological Cancer Market report?

Ans: The Types covered in the CAR-T Therapy for Hematological Cancer Market report are Target: CD19, Target: BCMA, Others

Recommended Reports

CAR-T Cell Therapy

Hematology & Malignancy

T-Cell Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CAR-T Therapy for Hematological Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Target: CD19

1.2.3 Target: BCMA

1.2.4 Others

1.3 Market by Application

1.3.1 Global CAR-T Therapy for Hematological Cancer Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Lymphoma

1.3.3 Multiple Myeloma

1.3.4 Leukemia

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CAR-T Therapy for Hematological Cancer Market Perspective (2019-2030)

2.2 Global CAR-T Therapy for Hematological Cancer Growth Trends by Region

2.2.1 Global CAR-T Therapy for Hematological Cancer Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 CAR-T Therapy for Hematological Cancer Historic Market Size by Region (2019-2024)

2.2.3 CAR-T Therapy for Hematological Cancer Forecasted Market Size by Region (2025-2030)

2.3 CAR-T Therapy for Hematological Cancer Market Dynamics

2.3.1 CAR-T Therapy for Hematological Cancer Industry Trends

2.3.2 CAR-T Therapy for Hematological Cancer Market Drivers

2.3.3 CAR-T Therapy for Hematological Cancer Market Challenges

2.3.4 CAR-T Therapy for Hematological Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CAR-T Therapy for Hematological Cancer Players by Revenue

3.1.1 Global Top CAR-T Therapy for Hematological Cancer Players by Revenue (2019-2024)

3.1.2 Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Players (2019-2024)

3.2 Global CAR-T Therapy for Hematological Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by CAR-T Therapy for Hematological Cancer Revenue

3.4 Global CAR-T Therapy for Hematological Cancer Market Concentration Ratio

3.4.1 Global CAR-T Therapy for Hematological Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CAR-T Therapy for Hematological Cancer Revenue in 2023

3.5 Global Key Players of CAR-T Therapy for Hematological Cancer Head office and Area Served

3.6 Global Key Players of CAR-T Therapy for Hematological Cancer, Product and Application

3.7 Global Key Players of CAR-T Therapy for Hematological Cancer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CAR-T Therapy for Hematological Cancer Breakdown Data by Type

4.1 Global CAR-T Therapy for Hematological Cancer Historic Market Size by Type (2019-2024)

4.2 Global CAR-T Therapy for Hematological Cancer Forecasted Market Size by Type (2025-2030)

5 CAR-T Therapy for Hematological Cancer Breakdown Data by Application

5.1 Global CAR-T Therapy for Hematological Cancer Historic Market Size by Application (2019-2024)

5.2 Global CAR-T Therapy for Hematological Cancer Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America CAR-T Therapy for Hematological Cancer Market Size (2019-2030)

6.2 North America CAR-T Therapy for Hematological Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America CAR-T Therapy for Hematological Cancer Market Size by Country (2019-2024)

6.4 North America CAR-T Therapy for Hematological Cancer Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CAR-T Therapy for Hematological Cancer Market Size (2019-2030)

7.2 Europe CAR-T Therapy for Hematological Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe CAR-T Therapy for Hematological Cancer Market Size by Country (2019-2024)

7.4 Europe CAR-T Therapy for Hematological Cancer Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CAR-T Therapy for Hematological Cancer Market Size (2019-2030)

8.2 Asia-Pacific CAR-T Therapy for Hematological Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific CAR-T Therapy for Hematological Cancer Market Size by Region (2019-2024)

8.4 Asia-Pacific CAR-T Therapy for Hematological Cancer Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CAR-T Therapy for Hematological Cancer Market Size (2019-2030)

9.2 Latin America CAR-T Therapy for Hematological Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America CAR-T Therapy for Hematological Cancer Market Size by Country (2019-2024)

9.4 Latin America CAR-T Therapy for Hematological Cancer Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size (2019-2030)

10.2 Middle East & Africa CAR-T Therapy for Hematological Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Country (2019-2024)

10.4 Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis CAR-T Therapy for Hematological Cancer Introduction

11.1.4 Novartis Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024)

11.1.5 Novartis Recent Development

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Details

11.2.2 Gilead Sciences Business Overview

11.2.3 Gilead Sciences CAR-T Therapy for Hematological Cancer Introduction

11.2.4 Gilead Sciences Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024)

11.2.5 Gilead Sciences Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Introduction

11.3.4 Bristol-Myers Squibb Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 J&J

11.4.1 J&J Company Details

11.4.2 J&J Business Overview

11.4.3 J&J CAR-T Therapy for Hematological Cancer Introduction

11.4.4 J&J Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024)

11.4.5 J&J Recent Development

11.5 JW Therapeutics

11.5.1 JW Therapeutics Company Details

11.5.2 JW Therapeutics Business Overview

11.5.3 JW Therapeutics CAR-T Therapy for Hematological Cancer Introduction

11.5.4 JW Therapeutics Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024)

11.5.5 JW Therapeutics Recent Development

11.6 FOSUNKite

11.6.1 FOSUNKite Company Details

11.6.2 FOSUNKite Business Overview

11.6.3 FOSUNKite CAR-T Therapy for Hematological Cancer Introduction

11.6.4 FOSUNKite Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024)

11.6.5 FOSUNKite Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Gilead Sciences

Bristol–Myers Squibb

J & J

JW Therapeutics

FOSUNKite

List of Tables

Table 1. Global CAR-T Therapy for Hematological Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Target: CD19

Table 3. Key Players of Target: BCMA

Table 4. Key Players of Others

Table 5. Global CAR-T Therapy for Hematological Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global CAR-T Therapy for Hematological Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global CAR-T Therapy for Hematological Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global CAR-T Therapy for Hematological Cancer Market Share by Region (2019-2024)

Table 9. Global CAR-T Therapy for Hematological Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global CAR-T Therapy for Hematological Cancer Market Share by Region (2025-2030)

Table 11. CAR-T Therapy for Hematological Cancer Market Trends

Table 12. CAR-T Therapy for Hematological Cancer Market Drivers

Table 13. CAR-T Therapy for Hematological Cancer Market Challenges

Table 14. CAR-T Therapy for Hematological Cancer Market Restraints

Table 15. Global CAR-T Therapy for Hematological Cancer Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global CAR-T Therapy for Hematological Cancer Market Share by Players (2019-2024)

Table 17. Global Top CAR-T Therapy for Hematological Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy for Hematological Cancer as of 2023)

Table 18. Ranking of Global Top CAR-T Therapy for Hematological Cancer Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by CAR-T Therapy for Hematological Cancer Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of CAR-T Therapy for Hematological Cancer, Headquarters and Area Served

Table 21. Global Key Players of CAR-T Therapy for Hematological Cancer, Product and Application

Table 22. Global Key Players of CAR-T Therapy for Hematological Cancer, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global CAR-T Therapy for Hematological Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Type (2019-2024)

Table 26. Global CAR-T Therapy for Hematological Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Type (2025-2030)

Table 28. Global CAR-T Therapy for Hematological Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Application (2019-2024)

Table 30. Global CAR-T Therapy for Hematological Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global CAR-T Therapy for Hematological Cancer Revenue Market Share by Application (2025-2030)

Table 32. North America CAR-T Therapy for Hematological Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America CAR-T Therapy for Hematological Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America CAR-T Therapy for Hematological Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe CAR-T Therapy for Hematological Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe CAR-T Therapy for Hematological Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe CAR-T Therapy for Hematological Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific CAR-T Therapy for Hematological Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific CAR-T Therapy for Hematological Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific CAR-T Therapy for Hematological Cancer Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America CAR-T Therapy for Hematological Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America CAR-T Therapy for Hematological Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America CAR-T Therapy for Hematological Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 47. Novartis Company Details

Table 48. Novartis Business Overview

Table 49. Novartis CAR-T Therapy for Hematological Cancer Product

Table 50. Novartis Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024) & (US$ Million)

Table 51. Novartis Recent Development

Table 52. Gilead Sciences Company Details

Table 53. Gilead Sciences Business Overview

Table 54. Gilead Sciences CAR-T Therapy for Hematological Cancer Product

Table 55. Gilead Sciences Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024) & (US$ Million)

Table 56. Gilead Sciences Recent Development

Table 57. Bristol-Myers Squibb Company Details

Table 58. Bristol-Myers Squibb Business Overview

Table 59. Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Product

Table 60. Bristol-Myers Squibb Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024) & (US$ Million)

Table 61. Bristol-Myers Squibb Recent Development

Table 62. J&J Company Details

Table 63. J&J Business Overview

Table 64. J&J CAR-T Therapy for Hematological Cancer Product

Table 65. J&J Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024) & (US$ Million)

Table 66. J&J Recent Development

Table 67. JW Therapeutics Company Details

Table 68. JW Therapeutics Business Overview

Table 69. JW Therapeutics CAR-T Therapy for Hematological Cancer Product

Table 70. JW Therapeutics Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024) & (US$ Million)

Table 71. JW Therapeutics Recent Development

Table 72. FOSUNKite Company Details

Table 73. FOSUNKite Business Overview

Table 74. FOSUNKite CAR-T Therapy for Hematological Cancer Product

Table 75. FOSUNKite Revenue in CAR-T Therapy for Hematological Cancer Business (2019-2024) & (US$ Million)

Table 76. FOSUNKite Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

Table 80. Authors List of This Report

List of Figures

Figure 1. CAR-T Therapy for Hematological Cancer Picture

Figure 2. Global CAR-T Therapy for Hematological Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global CAR-T Therapy for Hematological Cancer Market Share by Type: 2023 VS 2030

Figure 4. Target: CD19 Features

Figure 5. Target: BCMA Features

Figure 6. Others Features

Figure 7. Global CAR-T Therapy for Hematological Cancer Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global CAR-T Therapy for Hematological Cancer Market Share by Application: 2023 VS 2030

Figure 9. Lymphoma Case Studies

Figure 10. Multiple Myeloma Case Studies

Figure 11. Leukemia Case Studies

Figure 12. CAR-T Therapy for Hematological Cancer Report Years Considered

Figure 13. Global CAR-T Therapy for Hematological Cancer Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global CAR-T Therapy for Hematological Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global CAR-T Therapy for Hematological Cancer Market Share by Region: 2023 VS 2030

Figure 16. Global CAR-T Therapy for Hematological Cancer Market Share by Players in 2023

Figure 17. Global Top CAR-T Therapy for Hematological Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy for Hematological Cancer as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by CAR-T Therapy for Hematological Cancer Revenue in 2023

Figure 19. North America CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America CAR-T Therapy for Hematological Cancer Market Share by Country (2019-2030)

Figure 21. United States CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe CAR-T Therapy for Hematological Cancer Market Share by Country (2019-2030)

Figure 25. Germany CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific CAR-T Therapy for Hematological Cancer Market Share by Region (2019-2030)

Figure 33. China CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America CAR-T Therapy for Hematological Cancer Market Share by Country (2019-2030)

Figure 41. Mexico CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa CAR-T Therapy for Hematological Cancer Market Share by Country (2019-2030)

Figure 45. Turkey CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE CAR-T Therapy for Hematological Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Novartis Revenue Growth Rate in CAR-T Therapy for Hematological Cancer Business (2019-2024)

Figure 49. Gilead Sciences Revenue Growth Rate in CAR-T Therapy for Hematological Cancer Business (2019-2024)

Figure 50. Bristol-Myers Squibb Revenue Growth Rate in CAR-T Therapy for Hematological Cancer Business (2019-2024)

Figure 51. J&J Revenue Growth Rate in CAR-T Therapy for Hematological Cancer Business (2019-2024)

Figure 52. JW Therapeutics Revenue Growth Rate in CAR-T Therapy for Hematological Cancer Business (2019-2024)

Figure 53. FOSUNKite Revenue Growth Rate in CAR-T Therapy for Hematological Cancer Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global CAR T Cell Service Market Research Report 2024

CAR T Cellular Immunotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Drug based on CAR T Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CAR T Cell Development Service Market Research Report 2024

Global Autologous CAR T Cell Therapy Market Research Report 2024

Global CAR T cell Therapy Drug Market Research Report 2025

Global CAR T Cell Manufacturing Service Market Research Report 2024

Global Drug based on CAR T Cell Market Research Report 2025

Global CAR T Cell Therapy Agents Market Research Report 2025

CAR T Cell Based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs Based on CAR T cell Market Research Report 2025

Global CD19 targeted CAR T Cell Therapy Market Research Report 2024

Global BCMA targeted CAR T Cell Therapy Market Research Report 2025

Global CAR T Cell Immunotherapy Market Insights Forecast to 2030

Global T Cell Immunotherapy Market Research Report 2025

Global Gene Modifying Immunotherapy for Blood Cancer Market Insights Forecast to 2030

Chimeric Antigen Receptor CAR T Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

CAR T Therapy in Haematological Malignancy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global TCR T Cellular Immunotherapy Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions